Curcumol ameliorates diabetic retinopathy via modulating fat mass and obesity-associated protein-demethylated MAF transcription factor G antisense RNA 1

Figure 1 Curcumol attenuates diabetic retinopathy progression in mouse models. A: The molecular configuration of curcumol; B: A schematic illustration of the animal model assembly; C: Systematic monitoring of blood glucose levels of all mice; D: Body weight measurements; E: Food intake; F: Water intake; G: Representative retinal morphology images obtained through hematoxylin and eosin staining; H-J: Quantitative real-time polymerase chain reaction analysis of mRNA expression levels of pro-inflammatory factors, including interleukin-6, interleukin-8, and monocyte chemoattractant protein-1. Data represent the mean ± SD, n = 5-7 per group. ^aP < 0.05, ^bP < 0.01, ^cP < 0.001. T1D: Type 1 diabetes; STZ: Streptozotocin; IL: Interleukin; MCP-1: Chemoattractant protein-1.